In a study published in journal Nature Communications, researchers at Weill Cornell Medicine identify a protein that increases the risk of cognitive impairment.

With this formal appointment, Dr. Cigdem Akman continues the exceptional leadership she has demonstrated over the past year in driving the overall expansion of the division’s clinical, research, and education programs.

The brain and spine tumor programs at NewYork-Presbyterian integrate multiple disciplines to provide comprehensive treatment strategies that include minimally invasive surgery, radiation therapies, and intra-arterial chemotherapy.